Metraipolis › archive › dc_669e2f136906

Revolutionizing cancer immunotherapy: T cell engagers beyond hematologic malignancies toward solid tumors — Europe PMC PMID:42245672

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42245672
DOI
10.3389/fimmu.2026.1774471
License (as archived)
solo-consultazione
Archived
2026-11-01T13:26:57.552Z
SHA-256 of the archived text
b4cef5c539fe132a021c8abb946f82b803426e46f1fe853fbd45acf72d9a418c
Stable URL of this page
https://metraipolis.com/documento/dc_669e2f136906

How to cite

Revolutionizing cancer immunotherapy: T cell engagers beyond hematologic malignancies toward solid tumors — Europe PMC PMID:42245672 — Europe PMC (en), https://europepmc.org/article/MED/42245672 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_669e2f136906 (Metraipolis archive dc_669e2f136906, sha256 b4cef5c539fe132a021c8abb946f82b803426e46f1fe853fbd45acf72d9a418c)
BibTeX
@misc{dc669e2f136906,
  title = {Revolutionizing cancer immunotherapy: T cell engagers beyond hematologic malignancies toward solid tumors — Europe PMC PMID:42245672},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42245672},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_669e2f136906; sha256 b4cef5c539fe132a021c8abb946f82b803426e46f1fe853fbd45acf72d9a418c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42245672. Agents can read the archived copy with the MCP tool read_document.